Nanoparticles
"Nanoparticles" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Nanometer-sized particles that are nanoscale in three dimensions. They include nanocrystaline materials; NANOCAPSULES; METAL NANOPARTICLES; DENDRIMERS, and QUANTUM DOTS. The uses of nanoparticles include DRUG DELIVERY SYSTEMS and cancer targeting and imaging.
| Descriptor ID |
D053758
|
| MeSH Number(s) |
J01.637.512.600
|
| Concept/Terms |
Nanocrystalline Materials- Nanocrystalline Materials
- Material, Nanocrystalline
- Materials, Nanocrystalline
- Nanocrystalline Material
- Nanocrystals
- Nanocrystal
|
Below are MeSH descriptors whose meaning is more general than "Nanoparticles".
Below are MeSH descriptors whose meaning is more specific than "Nanoparticles".
This graph shows the total number of publications written about "Nanoparticles" by people in this website by year, and whether "Nanoparticles" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 2 | 0 | 2 | | 2007 | 4 | 1 | 5 | | 2008 | 4 | 2 | 6 | | 2009 | 16 | 6 | 22 | | 2010 | 7 | 5 | 12 | | 2011 | 17 | 2 | 19 | | 2012 | 11 | 7 | 18 | | 2013 | 12 | 2 | 14 | | 2014 | 8 | 5 | 13 | | 2015 | 19 | 4 | 23 | | 2016 | 9 | 6 | 15 | | 2017 | 15 | 8 | 23 | | 2018 | 15 | 2 | 17 | | 2019 | 16 | 4 | 20 | | 2020 | 12 | 7 | 19 | | 2021 | 20 | 3 | 23 | | 2022 | 16 | 2 | 18 | | 2023 | 23 | 2 | 25 | | 2024 | 31 | 8 | 39 | | 2025 | 26 | 10 | 36 | | 2026 | 21 | 4 | 25 |
To return to the timeline, click here.
Below are the most recent publications written about "Nanoparticles" by people in Profiles.
-
Velazquez S, Juber MC, Okun M, Lau E, Ashkarran AA. Body mass index-specific nanoparticle protein corona signatures in late pregnancy. Nanoscale. 2026 Sep 10; 18(34):18571-18583.
-
Grattoni A, Paci MM, Arnold N, Aryal S, Artzi N, Bao G, Barcena AJR, Bentov-Arava E, Blanco E, Chua CYX, Corradetti B, Cryer AM, Decuzzi P, De Giorgi M, Fell C, Gao W, Govindaswamy B, Jiang W, Kara G, King MR, Krishnan S, Lagor WR, Lammers T, Larsen J, Manfredi F, Manickam DS, Margulis K, Melancon MP, Meeuwissen S, Miller MA, Mitchell MJ, Mitragotri S, Mojiri A, Cooke JP, Palanki R, Phukan I, Sun X, Stayton PS, Tanifum EA, Veiseh O, Villapol S, Wang J, Williams R, Arancibia RY, Zhang L, Kabanov A, Godin B. Nanomedicine beyond carriers - devices, cells & living therapeutics. Biomed Microdevices. 2026 Sep 08; 28(3).
-
Grumelot S, Mohammed N, Yerima G, Colonrosado J, Sadeghi SA, Fang F, Hilsen K, Shango B, Saei AA, Murray AM, Mitchell MJ, Borhan B, Sun L, Vali H, Mofrad MRK, Whitehead KA, Mahmoudi M. Lipid Nanoparticle Protein Coronas Arise through Lipoprotein Fusion Rather Than Shell-like Adsorption. Nano Lett. 2026 08 26; 26(33):10943-10953.
-
Safford HC, Geisler HC, Thatte AS, Liao KC, Poirier A, Padilla M, Yamagata HM, Agrawal A, Murray AM, Hamilton AG, Swingle KL, Fitzgerald E, Chalom O, Wan Y, Mitchell MJ. Enhancing Lipid Nanoparticle-Mediated Circular RNA and mRNA Expression in the Placenta through Inhibition of IFNAR-JAK-STAT Signaling. Nano Lett. 2026 08 26; 26(33):10980-10991.
-
Wang S, Zhong Y, Wang C, Tian M, Bennett JL, Bliss-Moreau E, Xue Y, Yu C, Hou X, Zheng YY, Li H, Liu Z, Cao D, Kang DD, Deng B, Dong Y. Overcoming the blood-brain barrier using central nervous system-accessing lipid nanoparticles for enhanced mRNA therapeutics. Proc Natl Acad Sci U S A. 2026 Aug 18; 123(33):e2538147123.
-
Trujeque DM, Prabhune AG, Figueroa-Morales N, Catalano CE, Hough LE. Testing Bound-State Diffusion as a Model for Mucosal Transport of Nanoparticles. ACS Appl Bio Mater. 2026 Aug 03; 9(15):6941-6951.
-
Padilla MS, Li JJ, Zhang Q, Patwari K, Shi S, Yamagata HM, Joseph RA, Hymms BN, Teerdhala SV, Fitzgerald E, Chalom OZ, Gupta K, Alameh MG, Weissman D, Le AD, Mitchell MJ. Lipid Nanoparticle Co-Delivery of mRNA and a Small Molecule Drug for Oral Cancer Chemoimmunotherapy. Adv Mater. 2026 Aug; 38(47):e73721.
-
Zeng Y, Xu J, Wang J, Xue L, Liu J, Geisler HC, Ma X, Melamed JR, Shi Q, Padilla MS, Luo Z, Zhu J, Thatte AS, Figueroa-Espada CG, Ang MJY, Murray AM, Yamagata HM, Kim D, Metzloff AE, Weissman D, Mitchell MJ. mRNA lipid nanoparticle cancer vaccine platform delivering multiple STING activators for enhanced antitumor activity. Proc Natl Acad Sci U S A. 2026 Jul 14; 123(28):e2525718123.
-
Jacques S, Gaikwad H, Pillatzke J, Moghimi SM, Simberg D. Bioorthogonal tuning of nanosurface opsonisation via click coupling of a complement fusion protein inhibitor. Chem Commun (Camb). 2026 Jul 03; 62(51):12859-12862.
-
Kane GI, Diaz-Infante MB, Wigglesworth K, Lusi E, Brassil M, Rozen EJ, Kady J, Mori H, Lukas J, Naylor T, Dinnell RW, Murphy KC, Alarcon CBB, Ruscetti M, Brehm M, Shohet JM, Atukorale PU. Tumor Homing Nanoparticle Immunotherapy for Acute Clearance and Mitigation of T-cell Exhaustion in Humanized High-Risk Neuroblastoma. Mol Cancer Ther. 2026 Jul 02; 25(7):1144-1156.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|